Arrakis Therapeutics
Waltham, United States · $113.0M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 51–200
- Business Model
- B2B
- Website
- arrakistx.com
- Total Funding
- $113.0M
- Last Round
- $75.0M Series CNov 2020
- Rounds
- 3
About
Arrakis Therapeutics is a biotech company pioneering RNA small molecule (rSM) medicines targeting RNA structures for drug discovery.
Summary
Arrakis Therapeutics is a Biotech company based in Waltham, United States. It has raised $113.0M in total across 3 rounds, most recently a $75.0M Series C round in Nov 2020. Investors include Nextech Invest, venBIO Partners and Canaan Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company